KOL Perspectives: JAK Inhibitor Safety in IBD

Market: Pharmaceuticals and Healthcare

Global, 31 pages report, published by GlobalData

Report ThumbnailMay-2018
KOL Perspectives: JAK Inhibitor Safety in IBD

Summary

This KOL Insight briefing focuses on the potential use of selective JAK inhibitors in IBD.

The briefing includes analysis of KOL opinion on the following topic areas -
- Maintenance data for selective JAKs in Crohn’s disease
- Differentiating strategies for selective and non-selective JAKs in IBD
- Choice of primary endpoints for IBD trials
- Selective JAKs’ expected efficacy in UC
- Real-world use of JAKs in IBD

Key Highlights

- KOLs a

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: JAK Inhibitor Safety in IBDProduct ThumbnailKOL Perspectives: JAK Inhibitor Safety in IBD, Industry ReportProduct #: 1190887
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved